Oblenio Bio aims to transform the treatment of refractory autoimmune diseases through innovative therapies, specifically focusing on their tri-specific T-cell engager, LBL-051, designed to reset the immune system
Oblenio Bio aims to transform the treatment of refractory autoimmune diseases through innovative therapies, specifically focusing on their tri-specific T-cell engager, LBL-051, designed to reset the immune system.